300+ investors in your industry, stage, and region Get
Any industry
Hospitality
Video Games
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Energy
SaaS
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Wellness
Education
Medical Device
Automotive
eSports
Sports
Legal
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Medical
Web3
Theatre
Recruiting
Crowdfunding
Infrastructure
Venture Capital
Beauty
Fashion
Social
Celebrity
LGBT
Climate
Cannabis
Wine and Spirits
Mobile Apps
Life Science
Food and Beverage
Publishing
Art
Music
Real Estate
Sporting Goods
FinTech
Finance
Digital Media
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Sustainability
Proptech
Hardware
Impact
Transportation
Biotech
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
Japan
South Korea
Singapore
Burkina Faso
LATAM
Brazil
Africa
Gibraltar
Egypt
Oceania
Taiwan
Zimbabwe
Tunisia
Sweden
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Kyrgyzstan
Haiti
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Puerto Rico
Oman
Poland
Guernsey
Cameroon
Colombia
Armenia
China
Costa Rica
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Jamaica
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Uganda
Myanmar
Turkey
Uruguay
Moldova
Morocco
Seychelles
Botswana
Paraguay
South Africa
France
Denmark
Georgia
Ghana
Iraq
Portugal
Philippines
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Angola
Europe
Cyprus
Spain
Qatar
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Faroe Islands
Estonia
Bahrain
Bahamas
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Lithuania
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Chemelot Ventures, VC Fund

Chemelot Ventures

VC Fund

Urmond, The Netherlands

Chemelot Ventures is an active regional venture capital investor in materials and life sciences in the south of The Netherlands. They have a strong focus on value enhancement of their portfolio companies by using their network and the network of their LP's, DSM Nederland, Limburg Province, regional development agency LIOF and Rabobank.

Total investments:
16
Last investment:
Lead investor:
50%
Fund size:
$20M
Last fund:

Last updated:

Industries Chemelot Ventures invests in

BiotechnologyMedicalHealth CareLife ScienceManufacturing

Stages Chemelot Ventures invests in

Funding RoundSeries ASeed

Countries Chemelot Ventures invests in

The Netherlands

Contacts

NameEmailPhoneSocials
Patrick Claessen Patrick Claessen

Sign up to unlock verified contacts

Unlock Contacts

Investment Focus

Industry

  • Biotechnology 7 (44%)
  • Medical 5 (31%)
  • Health Care 4 (25%)
  • Life Science 3 (19%)
  • Manufacturing 3 (19%)
See all 24 industries →

Stage

  • Funding Round 9 (56%)
  • Series A 4 (25%)
  • Seed 1 (6%)

Team

NameTitleInvestmentsLinksEmail
Casper Bruens
Casper Bruens Director
Director Total investments: 0
Find email
Marcel Kloosterman
Marcel Kloosterman Senior Investment Manager
Senior Investment Manager Total investments: 6
Find email
Patrick Claessen
Patrick Claessen Senior Investment Manager
Senior Investment Manager Total investments: 4
Find email

Investments

CompanyDescriptionRoundLinks
ReSolved Technologies ReSolved Technologies
ReSolved Technologies are dedicated to increase the circularity of engineering plastics by addressing complex waste streams. They do this by extracting valuable plastics from these difficult-to-recycle waste streams and convert them to recycled material of near-virgin quality that is suited for closed-loop recycling in high-end markets. $1.1M / Seed / Aug 28, 2023
Black Bear Carbon Black Bear Carbon
Carbon black is a form of elemental carbon that is manufactured by the controlled vapour-phase pyrolysis and partial combustion of hydrocarbons. Several processes have been used to produce carbon black, including the oil-furnace, impingement (channel), lampblack, thermal (decomposition of natural gas) and acetylene (decomposition) processes.Carbon blacks are commonly referred to by the process or the source material from which they are made, e.g. furnace black, lampblack, thermal black, acetylene black and channel black. The different grades from the various processes have certain unique characteristics, but it is now possible to produce reasonable approximations of most of these grades using the oil-furnace process, by which more than 95% of the total output of carbon black is produced. $12.1M / Sep 07, 2018
Health Value Creation Health Value Creation
Health Value Creation is developing two surgical devices, a diagnostic tool and a trocar closure device. The first device helps prevent anastomotic leakages after bowel surgery by predicting the quality of the anastomosis during surgery, thereby reducing post-operative complications and lowering healthcare costs. The second device is a trocarclosure device for faster, safer and more secure suturing after laparoscopic surgery, resulting in a reduction of the chances of wound herniation. $2.2M / Series A / Dec 22, 2017
Mito Medical Products Mito Medical Products
Mito Medical is developing an innovative diagnostic device that measures vascularity (blood-vessel formation) in the breast and aims to replace the often harmful X-ray cancer screening examination. This technology enables pain-free breast cancer screening with no adverse health risks in both younger and older women, at an earlier stage than iscurrently the case. Oct 24, 2017
TripleMed TripleMed
TripleMed is developing minimally invasive products against aneurysms, without the need for incisions. The first product fills the aneurysm and prevents blood from entering, whilst leaving a channel for the blood to flow through to reach the other arteries. This enables a better and longer-lasting solution to the problem of aortic aneurysms. $2.2M / Series A / Sep 18, 2017
Kriya Materials Kriya Materials
Kriya Materials is the innovative developer and manufacturer of various metal oxide nano particles as well as their downstream dispersions and functional coating products thereof. Coatings play an important role in our everyday life, although often not recognized by those who do not master the art. Coatings are a big market and many products fallunder this category. Kriya Materials focuses itself on the development and manufacturing of various nano metal oxides which it uses internally for the development and production of very high end coatings.The coatings made by Kriya Materials are applied in a wide range of markets, some examples are the Plasma Panel and LCD industry, from Smartphone to touch panels to glass surfaces. $3.3M / Series A / Sep 13, 2017
Cristal Therapeutics Cristal Therapeutics
Cristal Therapeutics is a pharmaceutical company developing a new class of nanomedicine based on its proprietary polymeric technologies. It aims to find valuable solutions for medical needs by creating superior drug products. Both new and existing drugs can be combined with Cristal Therapeutics Polymeric Technologies, shortly abbreviated as CriPec.CriPec-based products are versatile as a crystal and allow to improve the treatment of various diseases. $13.6M / Jan 19, 2017
Matisse Pharmaceuticals Matisse Pharmaceuticals
Matisse Pharmaceuticals is a biotechnology company dedicated to development of pharmaceutical therapies to treat disorders that are associated with fulminant inflammation such as sepsis. The most advanced product in development is the heparin fraction M6229 for the treatment of severe sepsis and septic shock. $2.1M / Nov 17, 2016
Fortimedix Fortimedix
Fortimedix is a global leader in the field of endovascular stents. With full in-house stent development and manufacturing capabilities, they have been a trusted partner for over 15 years.As a leader in stent technology, they invest heavily in research & development which fosters innovation, enables continuous improvement, and fulfils theirdedication to operational excellence.At Fortimedix everything they do is inspired by their Mission and Vision. It is of great importance to us that their customers, employees and stakeholders know what they stand for and where they are going. $12.1M / Series A / Oct 12, 2016
Materiomics BV Materiomics BV
Materiomics BV is a biotech company located in Enschede, The Netherlands. The company has developed TopoChip. Materiomics BV designs and identifies the best surface for improved functionality and durability of medical and cell culture devices. $1.5M / Nov 13, 2015
See all 16 investments →

Co-Investors

Limburg Business Development Fund (LBDF) 4 deals together
Limburg Ventures Limburg Ventures 3 deals together Nedermaas Hightech Ventures Nedermaas Hightech Ventures 3 deals together BioGeneration Ventures BioGeneration Ventures 2 deals together NV Industriebank LIOF NV Industriebank LIOF 2 deals together
Utrecht University Holding and Management Innovation Fund 2 deals together

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Hospitality
Video Games
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Energy
SaaS
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Wellness
Education
Medical Device
Automotive
eSports
Sports
Legal
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Medical
Web3
Theatre
Recruiting
Crowdfunding
Infrastructure
Venture Capital
Beauty
Fashion
Social
Celebrity
LGBT
Climate
Cannabis
Wine and Spirits
Mobile Apps
Life Science
Food and Beverage
Publishing
Art
Music
Real Estate
Sporting Goods
FinTech
Finance
Digital Media
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Sustainability
Proptech
Hardware
Impact
Transportation
Biotech
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
Japan
South Korea
Singapore
Burkina Faso
LATAM
Brazil
Africa
Gibraltar
Egypt
Oceania
Taiwan
Zimbabwe
Tunisia
Sweden
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Kyrgyzstan
Haiti
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Puerto Rico
Oman
Poland
Guernsey
Cameroon
Colombia
Armenia
China
Costa Rica
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Jamaica
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Uganda
Myanmar
Turkey
Uruguay
Moldova
Morocco
Seychelles
Botswana
Paraguay
South Africa
France
Denmark
Georgia
Ghana
Iraq
Portugal
Philippines
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Angola
Europe
Cyprus
Spain
Qatar
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Faroe Islands
Estonia
Bahrain
Bahamas
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Lithuania
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Chemelot Ventures invest in?

Chemelot Ventures invests primarily in Biotechnology, Medical and Health Care startups, most often at Funding Round and Series A stage. Most of the 16 investments tracked by Shizune back companies in The Netherlands. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact Chemelot Ventures?

Public channels for Chemelot Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Chemelot Ventures?

The team at Chemelot Ventures includes Casper Bruens (Director), Marcel Kloosterman (Senior Investment Manager) and Patrick Claessen (Senior Investment Manager). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Chemelot Ventures Chemelot Ventures Find emails